Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer

Genetics in Medicine

Volumn 9, Issue 11, 2007, Pages 766-777

  Schlich Bakker, Kathryn J ^a   Ten Kroode, Herman F J ^a   Wárlám Rodenhuis, Carla C ^a   Van Den Bout, Jan ^b   Ausems, Margreet G E M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Barriers; Breast cancer patients; Decline; Genetic testing; Participation

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RISK; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC SCREENING; HEALTH EDUCATION; HUMAN; MAJOR CLINICAL STUDY; PATIENT PARTICIPATION; RISK ASSESSMENT;

ADULT; ATTITUDE TO HEALTH; BREAST NEOPLASMS; COUNSELING; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC SCREENING; HUMANS; MIDDLE AGED; MUTATION; QUESTIONNAIRES;

EID: 36248965183     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e318159a318     Document Type: Article

References (34)

1. King MC, Rowell S, Love SM. Inherited breast and ovarian cancer. What are the risks? What are the choices? JAMA 1993;269:1975-1980.
2. Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994;12:843-850.
3. Lerman C, Narod S, Schulman K, Hughes C, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patients decision making and outcomes. JAMA 1996;275:1885-1892.
4. Struewing JP, Lerman C, Kase RG, Giambarresi TR, et al. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev 1995;4:169-173.
5. Armstrong K, Calzone K, Stopfer J, Fitzgerald G, et al. Factors associated with decisions about clinical BRCA1/2 testing. Cancer Epidemiol Biomarkers Prev 2000;9:1251-1254.
6. Lodder LN, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, et al. Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? J Med Genet 1999;36:906-913.
7. Brandt R, Hartmann E, Ali Z, Tucci R, et al. Motivations and concerns of women considering genetic testing for breast cancer: a comparison between affected and at-risk probands. Genet Test 2002;6:203-205.
8. Bleiker EM, Hahn DEE, Aaronson NK. Psychosocial issues in cancer genetics. Acta Oncol 2003;42:276-286.
9. Biesecker BB, Ishibe N, Hadley DW, Giambarresi TR, et al. Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. Am J Med Genet 2000;93:257-263.
10. Lerman C, Schwartz MD, Lin TH, Hughes C, et al. The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol 1997;65:414-420.
11. Jacobsen PB, Valdimarsdottier HB, Brown KL, Offit K. Decision-making about genetic testing among women at familial risk for breast cancer. Psychosom Med 1997;59:459-466.
12. Geer KP, Ropka ME, Cohn WF, Jones SM, et al. Factors influencing Patients' decisions to decline cancer genetic counseling services. J Genet Couns 2001;10:25-40.
13. Peterson EA, Milliron KJ, Lewis KE, Goold SD, et al. Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. Cancer Epidemiol Biomarkers Prev 2002;11:79-87.
14. Foster C, Evans DGR, Eeles R, Eccles D, et al. Non-uptake of predictive genetic testing for BRCA1/2 among relatives of know carriers: attributes, cancer worry and barriers to testing in a multicenter clinical cohort. Genet Test 2004;8:23-29.
15. Lodder L, Frets PG, Trijsburg RW, Klijn JGM, et al. Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing. Am J Med Genet A 2003;119:266-272.
16. Peters N, Domchek SM, Rose A, Polis R, et al. Knowledge, attitudes, and utilization of BRCA1/2 testing among women with early-onset breast cancer. Genet Test 2005;9:48-53.
17. Van Asperen CJ, Van Dijk S, Zoeteweij MW, Timmermans DRM, et al. What do women really want to know? Motives for attending familial breast cancer clinics. J Med Genet 2002;39:410-414.
18. Julian-Reynier C, Eisinger F, Chabal F, Aurran Y, et al. Cancer genetic clinics: why do women who already have cancer attend? Eur J Cancer 1998;34:1549-1553.
19. Schwartz MD, Lerman C, Brogan B, Peshkin BN, et al. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients. Cancer Epidemiol Biomarkers Prev 2005;14:1003-1007.
20. Ropka ME, Wenzel J, Phillips EK, Siadaty M, et al. Uptake rates for breast cancer genetic testing: a systematic review. Cancer Epidemiol Biomarkers Prev 2006;15:840-855.
21. Cappelli M, Surh L, Humphreys L, Verma S, et al. Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer. Clin Genet 1999;55:419-430.
22. Evans DG, Lalloo F, Hopwood P, Maurice A, et al. Surgical decisions made by 158 women with hereditary breast cancer aged <50 years. Eur J Surg Oncol 2005;31:1112-1118.
23. Rosenstock IM. The Health Belief Model and preventive health behavior. Health Educ Monogr 1972;2:354-386.
24. Wárlám-Rodenhuis CC, Koot VCM, Van der Luijt RB, Vasen HFA, et al. A prospective study on predictive factors linked to the presence of BRCA1 and BRCA2 mutations in breast cancer patients. Eur J Cancer 2005;41:1409-1415.
25. Schlich-Bakker KJ, Wárlám-Rodenhuis CC, Van Echtelt J, Van den Bout J, et al. Short term psychological distress in patients actively approached for genetic counselling after diagnosis of breast cancer. Eur J Cancer 2006;42:2722-2728.
26. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
27. Razavi D, Delveaux N, Farvacques C, Robayes E. Screening for adjustment disorders and major depressive disorders in cancer in-patients. Br J Psychiatry 1990;156:79-83.
28. Horowitz M, Wilner N, Avarez W. Impact of event scale: a measure of subjective stress. Psychosom Med 1997;41:209-218.
29. Horowitz MJ. Stress response syndromes and their treatment. In: Goldenberger L, Breznitz S, editors. Handbook of stress. Theoretical and clinical aspects. New York: Free Press, 1982:711-732.
30. Pieterse AH, Ausems MGEM, Van Dulmen AM, Beemer FA, et al. Initial cancer genetic counselling consultation: change in counselees' cognitions and anxiety, and association with addressing their needs and preferences. Am J Med Genet A 2005;137:27-35.
31. Claes E, Evers-Kiebooms G, Boogaerts A, Decruyenaere M, et al. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet A 2003;116:11-19.
32. Bleiker EM, van der Ploeg HM, Hendriks JH, Ader HJ. Personality factors and breast cancer development: a prospective longitudinal study. J Natl Cancer Inst 1996;88:1478-1482.
33. Westbrook MT. A classification of coping behavior based on multi-dimensional scaling of similarity ratings. J Clin Psychol 1979;35:407-410.
34. Weitzel JN, McCaffrey SM, Nedelcu R, MacDonald DJ, et al. Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Arch Surg 2003;138:1323-1328.